ACA
Affinity Capital Advisors’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-7,410
| Closed | -$287K | – | 111 |
|
|
2022
Q1 | $287K | Buy |
7,410
+51
| +0.7% | +$1.98K | 0.09% | 91 |
|
|
2021
Q4 | $431K | Buy |
7,359
+20
| +0.3% | +$1.17K | 0.13% | 76 |
|
|
2021
Q3 | $435K | Hold |
7,339
| – | – | 0.15% | 74 |
|
|
2021
Q2 | $637K | Hold |
7,339
| – | – | 0.22% | 62 |
|
|
2021
Q1 | $605K | Hold |
7,339
| – | – | 0.22% | 59 |
|
|
2020
Q4 | $667K | Sell |
7,339
-730
| -9% | -$66.3K | 0.27% | 54 |
|
|
2020
Q3 | $323K | Sell |
8,069
-935
| -10% | -$37.4K | 0.18% | 72 |
|
|
2020
Q2 | $309K | Hold |
9,004
| – | – | 0.2% | 68 |
|
|
2020
Q1 | $282K | Sell |
9,004
-3,355
| -27% | -$105K | 0.21% | 74 |
|
|
2019
Q4 | $242K | Buy |
+12,359
| New | +$242K | 0.16% | 98 |
|